Last reviewed · How we verify

NCT04077203

Biofeedback of Glucose in Non-diabetic Participants

Completed NA Last updated 17 November 2020
What this trial tests

NA trial testing Biofeedback / No biofeedback in Blood Glucose in 50 participants. Completed in 30 November 2019.

Timeline
16 July 2019
Primary endpoint
30 November 2019
30 November 2019

Quick facts

Lead sponsorKlick Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment50
Start date16 July 2019
Primary completion30 November 2019
Estimated completion30 November 2019
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Klick Inc.

Who can join

18 and older, any sex, with Blood Glucose or Biofeedback. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc.). This study utilizes wearable continuous glucose (CGM) technology, which provides personalized feedback to participants to allow them to self-monitor their own glucose levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Glucose

Currently open trials in the same condition.

Other Klick Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04077203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing